Alpha Cognition (ACOG) Cash & Current Investments (2023 - 2026)
Alpha Cognition (ACOG) posted quarterly Cash & Current Investments of $66.1 million for Q4 2025, up 36.12% year-over-year from $48.6 million in Q4 2024, and up 86.44% quarter-over-quarter from $35.5 million in Q3 2025.
Alpha Cognition (ACOG) Cash & Current Investments (2023 - 2026) Analysis & Trends
Alpha Cognition's Cash & Current Investments history runs 3 years deep, the most recent figure standing at $66.1 million for Q4 2025.
- In Q4 2025, Cash & Current Investments rose 36.12% year-over-year to $66.1 million; the TTM figure through Dec 2025 stood at $66.1 million (up 36.12% YoY), while the FY2025 annual figure was $66.1 million, up 36.12% from the prior year.
- Cash & Current Investments for Q4 2025 stood at $66.1 million, up from $35.5 million in the prior quarter.
- The five-year high for Cash & Current Investments was $66.1 million in Q4 2025, with the low at $163678.0 in Q1 2024.
- The 3-year median for Cash & Current Investments is $19.6 million (2024), against an average of $24.2 million.
- Peak annual rise in Cash & Current Investments reached 27773.16% in 2025, while the deepest fall reached 36.12% in 2025.
- Alpha Cognition's Cash & Current Investments stood at $1.5 million in 2023, then jumped by 3149.36% to $48.6 million in 2024, then surged by 36.12% to $66.1 million in 2025.
- Business Quant data shows ACOG's Cash & Current Investments at $66.1 million in Q4 2025, $35.5 million in Q3 2025, and $39.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 836.99 Mn |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn | 41.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.44 Mn |
| Dec 31, 2025 | 66.11 Mn |
| Sep 30, 2025 | 35.46 Mn |
| Jun 30, 2025 | 39.46 Mn |
| Mar 31, 2025 | 45.62 Mn |
| Dec 31, 2024 | 48.56 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 163,678.00 |
| Dec 31, 2023 | 1.49 Mn |
| Sep 30, 2023 | 201,500.00 |